Selected article for: "ICU transfer and intensive care"

Author: Trimaille, Antonin; Thachil, Jecko; Marchandot, Benjamin; Curtiaud, Anaïs; Leonard-Lorant, Ian; Carmona, Adrien; Matsushita, Kensuke; Sato, Chisato; Sattler, Laurent; Grunebaum, Lelia; Hansmann, Yves; Fafi-Kremer, Samira; Jesel, Laurence; Ohana, Mickaël; Morel, Olivier
Title: D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients
  • Cord-id: le1ij6fp
  • Document date: 2020_12_24
  • ID: le1ij6fp
    Snippet: Background and Objective: Host defence mechanisms to counter virus infection include the activation of the broncho-alveolar haemostasis. Fibrin degradation products secondary to extravascular fibrin breakdown could contribute to the marked increase in D-Dimers during COVID-19. We sought to examine the prognostic value on lung injury of D-Dimers in non-critically ill COVID-19 patients without thrombotic events. Methods: This study retrospectively analysed hospitalized COVID-19 patients classified
    Document: Background and Objective: Host defence mechanisms to counter virus infection include the activation of the broncho-alveolar haemostasis. Fibrin degradation products secondary to extravascular fibrin breakdown could contribute to the marked increase in D-Dimers during COVID-19. We sought to examine the prognostic value on lung injury of D-Dimers in non-critically ill COVID-19 patients without thrombotic events. Methods: This study retrospectively analysed hospitalized COVID-19 patients classified according to a D-Dimers threshold following the COVID-19 associated haemostatic abnormalities (CAHA) classification at baseline and at peak (Stage 1: D-Dimers less than three-fold above normal; Stage 2: D-Dimers three- to six-fold above normal; Stage 3: D-Dimers six-fold above normal). The primary endpoint was the occurrence of critical lung injuries on chest computed tomography. The secondary outcome was the composite of in-hospital death or transfer to the intensive care unit (ICU). Results: Among the 123 patients included, critical lung injuries were evidenced in 8 (11.9%) patients in Stage 1, 6 (20%) in Stage 2 and 15 (57.7%) in Stage 3 (p = 0.001). D-Dimers staging at peak was an independent predictor of critical lung injuries regardless of the inflammatory burden assessed by CRP levels (OR 2.70, 95% CI (1.50–4.86); p < 0.001) and was significantly associated with increased in-hospital death or ICU transfer (14.9 % in Stage 1, 50.0% in Stage 2 and 57.7% in Stage 3 (p < 0.001)). D-Dimers staging at peak was an independent predictor of in-hospital death or ICU transfer (OR 2.50, CI 95% (1.27–4.93); p = 0.008). Conclusions: In the absence of overt thrombotic events, D-Dimers quantification is a relevant marker of critical lung injuries and dismal patient outcome.

    Search related documents:
    Co phrase search for related documents
    • abnormal coagulation and acute pulmonary embolism: 1, 2, 3
    • abnormal coagulation and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activate neutrophil and acute ards respiratory distress syndrome: 1
    • activate neutrophil and acute sars respiratory syndrome coronavirus: 1
    • activate neutrophil and lung alveolar: 1
    • acute ali lung injury and admission day: 1
    • acute ali lung injury and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and admission fibrinogen: 1
    • acute ards respiratory distress syndrome and admission value: 1, 2, 3
    • acute ards respiratory distress syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute ards respiratory distress syndrome and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung alveolar epithelial cell: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome develop and admission day: 1
    • acute pulmonary embolism and admission day: 1, 2, 3
    • acute pulmonary embolism and logistic regression model: 1
    • acute pulmonary embolism and lung alveolar: 1
    • acute sars respiratory syndrome coronavirus and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars respiratory syndrome coronavirus and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25